Spermidine / NRF2 Cancer Research Results

Sper, Spermidine: Click to Expand ⟱
Features:
Spermidine : Polyamine (natural small molecule)
Sources: Found in foods like wheat germ, soybeans, mushrooms, aged cheese, and fermented foods. Typical dietary intake is ~5–20 mg/day.Top food sources = wheat germ > soybeans > aged cheddar > mushrooms > rice bran/legumes.

Ripening / fermentation: especially in aged or fermented foods like cheese, where spermidine and other polyamines can rise during ripening because microbial activity and protein breakdown contribute to amine formation. That is one reason aged cheeses can rank unusually high.
Cooking: boiling and grilling significantly reduced polyamine content in many foods, whereas microwave and sous-vide tended to preserve more.

Primary Actions: Autophagy induction, mild ROS modulation, epigenetic regulation, and modulation of polyamine metabolism.
Pathway	                Effect of Spermidine
Autophagy (ATG genes)	↑ Induction, Beclin-1 activation
mTORC1 signaling	↓ Inhibition, promotes catabolic metabolism
p53/p21	                Modulation via epigenetic changes
Polyamine metabolism	Supports or stresses proliferating cells
ROS / redox balance	Mild modulation; sensitizes cancer cells to ROS stress
Context-dependent risk: High spermidine levels might support tumor growth in polyamine-addicted cancers; dose, timing, and tumor type matter.

Chemo interaction: Generally compatible; not expected to block ROS-dependent therapy at oral doses.

Spermidine, a biogenic polyamine that declines along with aging, shows promise in restoring antitumor immunity by enhancing mitochondrial fatty acid oxidation (FAO)

Spermidine — Cancer vs Normal Cell Effects
Rank Pathway / Axis Cancer Cells Normal Cells Label Primary Interpretation Notes
1 Autophagy induction (ATG program) ↑ autophagy → metabolic stress, growth restraint ↑ autophagy → cytoprotection, homeostasis Driver Autophagy-first mechanism Spermidine robustly induces autophagy independent of mTOR inhibition; cancer cells are more vulnerable to enforced catabolism
2 Epigenetic regulation (histone acetylation) ↓ histone acetylation (via HAT inhibition) ↓ acetylation (adaptive) Driver Chromatin-mediated transcriptional reprogramming Spermidine inhibits histone acetyltransferase activity, promoting a pro-autophagic, anti-proliferative transcriptional state
3 Polyamine metabolism / homeostasis Disrupted polyamine balance Homeostatic buffering Driver Metabolic vulnerability Cancer cells are highly dependent on polyamine flux; spermidine perturbs this balance
4 AMPK / mTOR nutrient-sensing axis ↑ AMPK; ↓ mTOR signaling ↑ AMPK (adaptive) Secondary Catabolic pressure Energy-sensing pathways reinforce autophagy and growth suppression
5 Mitochondrial function / bioenergetics ↓ metabolic flexibility ↑ mitochondrial efficiency Secondary Energy stress vs optimization Autophagy-driven mitochondrial turnover stresses tumor bioenergetics while benefiting normal cells
6 Reactive oxygen species (ROS) ↑ ROS (secondary, stress-linked) ↓ ROS Secondary Metabolism-linked redox shift ROS changes arise indirectly from autophagy and mitochondrial remodeling, not direct redox chemistry
7 NRF2 antioxidant response NRF2 (adaptive, secondary) NRF2 (protective) Adaptive Redox homeostasis reinforcement NRF2 activation reflects compensatory antioxidant signaling rather than a cytotoxic mechanism
8 Cell cycle / proliferation ↓ proliferation / ↑ arrest ↔ spared Phenotypic Cytostatic growth limitation Growth inhibition reflects sustained autophagy and epigenetic effects
9 Apoptosis sensitivity ↑ sensitivity to apoptosis (context-dependent) ↓ apoptosis Phenotypic Threshold-dependent cell death Apoptosis occurs when catabolic stress exceeds adaptive capacity


NRF2, nuclear factor erythroid 2-related factor 2: Click to Expand ⟱
Source: TCGA
Type: Antiapoptotic
Nrf2 is responsible for regulating an extensive panel of antioxidant enzymes involved in the detoxification and elimination of oxidative stress. Thought of as "Master Regulator" of antioxidant response.
-One way to estimate Nrf2 induction is through the expression of NQO1.
NQO1, the most potent inducer:
SFN 0.2 μM,
quercetin (2.5 μM),
curcumin (2.7 μM),
Silymarin (3.6 μM),
tamoxifen (5.9 μM),
genistein (6.2 μM ),
beta-carotene (7.2μM),
lutein (17 μM),
resveratrol (21 μM),
indol-3-carbinol (50 μM),
chlorophyll (250 μM),
alpha-cryptoxanthin (1.8 mM),
and zeaxanthin (2.2 mM)

1. Raising Nrf2 enhances the cell's antioxidant defenses and ↓ROS. This strategy is used to decrease chemo-radio side effects.
2. Downregulating Nrf2 lowers antioxidant defenses and ↑ROS. In cancer cells this leads to DNA damage, and cell death.
3. However there are some cases where increasing Nrf2 paradoxically causes an increase in ROS (cancer cells). Such as cases of Mitochondial overload, signal crosstalk, reductive stress

-In some cases, Nrf2 is overexpressed in cancer cells, which can lead to the activation of genes involved in cell proliferation, angiogenesis, and metastasis. This can contribute to the development of resistance to chemotherapy and targeted therapies.
-Increased Nrf2 expression: Lung, Breast, Colorectal, Prostrate.
Decreased Nrf2 expression: Skine, Liver, Pancreatic.
-Nrf2 is a cytoprotective transcription factor which demonstrated both a negative effect as well as a positive effect on cancer
- "promotes Nrf2 translocation from the cytoplasm to the nucleus," means facilitates the movement of Nrf2 into the nucleus, thereby enhancing the cell's antioxidant and cytoprotective responses. -Major regulator of Nrf2 activity in cells is the cytosolic inhibitor Keap1.

Nrf2 Inhibitors and Activators
Nrf2 Inhibitors: Brusatol, Luteolin, Trigonelline, VitC, Retinoic acid, Chrysin
Nrf2 Activators: SFN, OPZ EGCG, Resveratrol, DATS, CUR, CDDO, Api
- potent Nrf2 inducers from plants include sulforaphane, curcumin, EGCG, resveratrol, caffeic acid phenethyl ester, wasabi, cafestol and kahweol (coffee), cinnamon, ginger, garlic, lycopene, rosemany

Nrf2 plays dual roles in that it can protect normal tissues against oxidative damage and can act as an oncogenic protein in tumor tissue.
– In healthy tissues, NRF2 activation helps protect cells from oxidative damage and maintains cellular homeostasis.
– In many cancers, constitutive activation of NRF2 (often through mutations in NRF2 itself or loss-of-function mutations in KEAP1) leads to an enhanced antioxidant capacity.
– This upregulation can promote tumor cell survival by enabling cancer cells to thrive under oxidative stress, resist chemotherapeutic agents, and sustain metabolic reprogramming.
– Elevated NRF2 levels have been implicated in promoting tumor growth, metastasis, and resistance to therapy in various malignancies.
– High or sustained NRF2 activity is frequently associated with aggressive tumor phenotypes, poorer prognosis, and decreased overall survival in several cancer types.
– While its activation is essential for protecting normal cells from oxidative stress, aberrant or sustained NRF2 activation in tumor cells can lead to enhanced survival, therapeutic resistance, and tumor progression.

NRF2 inhibitors: (to decrease antioxidant defenses and increase cell death from ROS).
-Brusatol: most cited natural inhibitors of Nrf2.
-Luteolin: luteolin can reduce Nrf2 activity in specific cancer models and may enhance cell sensitivity to chemotherapy. However, luteolin is also known as an antioxidant, and its influence on Nrf2 can sometimes be context dependent.
-Apigenin: certain studies to down‑regulate Nrf2 in cancer cells: Dose and context dependent .
-Oridonin:
-Wogonin: although its effects might be cell‑ and dose‑specific.
- Withaferin A

Scientific Papers found: Click to Expand⟱
4892- Sper,  erastin,    Spermidine inactivates proteasome activity and enhances ferroptosis in prostate cancer
- in-vitro, Pca, PC3 - in-vivo, Pca, NA
Ferroptosis↑, lipid-P↑, Iron↑, eff↑, HO-1↑, NRF2↑, ROS↑, AntiTum↑, eff↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

Ferroptosis↑, 1,   HO-1↑, 1,   Iron↑, 1,   lipid-P↑, 1,   NRF2↑, 1,   ROS↑, 1,  

Cell Death

Ferroptosis↑, 1,  

Drug Metabolism & Resistance

eff↓, 1,   eff↑, 1,  

Functional Outcomes

AntiTum↑, 1,  
Total Targets: 10

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: NRF2, nuclear factor erythroid 2-related factor 2
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:386  Target#:226  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page